Autres langues Abbott Laboratories

Actions

ABT

US0028241000

Equipement, fournitures et distribution médicale

Marché Fermé - NYSE 22:02:42 09/10/2026			Varia. 5j.	Varia. 1 janv.
99,60 ^USD	+1,13 %		+2,15 %	-20,50 %

09/10	Trump a déclaré 517 transactions sur des titres en août, dont l’achat d’actions Meta pour un montant pouvant atteindre 25 millions de dollars	MT
07/10	Abbott Laboratories : Barclays favorable sur le dossier	ZM

Autres langues

09/10	Trump Disclosed 517 Securities Transactions in August, Including Up to $25 Million Meta Purchase
07/10	Abbott introduces Ensure® Max Protein 3-in-1 Muscle Support, bringing the benefits of a supplement stack into one scoop
07/10	Abbott Introduces Ensure Max Protein 3-In-1 Muscle Support Protein Powder
05/10	Abbott Laboratories Receives FDA Approval for New CardioMEMS HF System capabilities
05/10	Abbott Laboratories Receives FDA Approval to Include Interactive Features in CardioMEMS Heart Monitor
05/10	Abbott receives FDA approval for new CardioMEMS HF System capabilities that help patients engage in the care of their heart condition
02/10	Schwacher Arbeitsmarkt gibt Aktien Auftrieb
02/10	Afternoon Meeting: La debilidad del empleo impulsa a las bolsas
02/10	Weak Jobs Lead to Stronger Stocks
02/10	Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms
02/10	Analystenempfehlungen: Adidas, Hensoldt, Lindt, Airbnb, Hewlett Packard, Nike…
02/10	Analyst recommendations: Airbnb, Hewlett Packard Enterprise, Fair Isaac, Nike…
30/09	Abbott Launches Simplescreen Crc Blood Test in the U.S
30/09	Abbott Launches SimpleScreen Blood Test for Colorectal Cancer
30/09	Abbott hosts conference call for third-quarter earnings
30/09	Abbott launches SimpleScreen™ CRC blood test, joining Cologuard Plus® in its colorectal cancer screening portfolio
25/09	Abbott Laboratories : Landmark study in people with Type 2 diabetes using basal insulin shows continuous glucose monitoring, including Abbott’s Libre technology, associated with lower risk of death and cardiovascular complications
24/09	US FDA advisers endorse Grail cancer test's benefits in key vote
23/09	Abbott and Berry Street team up on personalized nutrition tracking
23/09	US companies face rise in cyber attacks
23/09	Abbott and Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health
23/09	Abbott And Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health
21/09	Grail rallies as FDA staff flags no major concerns for multi-cancer test
18/09	Trinity Heart Experts First in the Quad Cities to Use New Afib Technology
17/09	Abbott Laboratories Declares Quarterly Dividend, Payable on Nov. 16, 2026